Mr. Ganot is Co-Founder, President and Chief Executive Officer of Solid Biosciences and a member of the board of directors.
He started Solid in 2013 to find treatments, and potentially a cure, for Duchenne muscular dystrophy, a disease that afflicts his son Eytani.
Prior to starting Solid, Mr. Ganot was an investment banker at JPMorgan Chase in London, specializing in hedge fund driven equities business for the firm. Mr. Ganot also worked at Nomura Securities in London, Hong Kong and New York, where he managed relationships with investors and clients of the firm. Prior to Nomura, Mr. Ganot was a senior salesperson for Lehman Brothers’ European Equities business.
Mr. Ganot embarked on a banking career after practicing law at the Israeli law-firm, Haim Zadok & Co, where his focus was private equity law and mergers and acquisitions. Prior to practicing law, Mr. Ganot was division head at Vir-Tech, a laser engraving business, and a captain in the Israel Defense Forces. Mr. Ganot received his MBA from London Business school and holds law and business degrees from the IDC in Herzliya, Israel.